5F-PB-22
 | |
|---|---|
| Systematic (IUPAC) name | |
| 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester | |
| Clinical data | |
| Legal status | ? |
| Identifiers | |
| CAS number | 1400742-41-7 |
| ATC code | ? |
| ChemSpider | 29341631 |
| Chemical data | |
| Formula | C23H21FN2O2 |
| Mol. mass | 376.42 g/mol |
| |
| |
5F-PB-22 or 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester is a designer drug and a possible cannabinoid agonist. The structure of 5F-PB-22 appears to utilise an understanding of structure-activity relationships within the indole class of cannabimimetics, although its design origins are unclear. 5F-PB-22 represents a structurally unique synthetic cannabinoid chemotype, since it contains an ester linker at the indole 3-position, rather than the precedented ketone of JWH-018 and its analogues, or the amide of SDB-001 and its analogues. 5F-PB-22 is the terminally fluorinated analogue of QUPIC (also known as PB-22), just as AM-2201 is the similarly fluorinated analogue of JWH-018. No information regarding the in vitro or in vivo activity of 5F-PB-22 has been published, and only anecdotal reports are known of its pharmacology in humans or other animals.
Detection
A forensic standard of 5F-PB-22 is available, and the compound has been posted on the Forendex website of potential drugs of abuse.[1]
See also
References
- ↑ 5F-PB-22 page on Forendex